1. COVID-19 Vaccine Uptake Among People Living with HIV
- Author
-
Timothy W Menza, Michelle Barber, Jeff Capizzi, Amy I. Zlot, and Lea Bush
- Subjects
Original Paper ,Vaccines ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Social Psychology ,business.industry ,Anti-HIV Agents ,Vaccination ,Human immunodeficiency virus (HIV) ,Public Health, Environmental and Occupational Health ,HIV ,COVID-19 ,HIV Infections ,medicine.disease_cause ,Infectious Diseases ,Environmental health ,medicine ,Public health surveillance ,Humans ,business - Abstract
People living with HIV (PLWH) are at greater risk for severe COVID-19 and are a priority population for COVID-19 vaccination. As of June 15, 2021, 61.6% of PLWH in Oregon received ≥ 1 COVID-19 vaccine dose. Younger PLWH, Hispanic/Latinx PLWH and PLWH who inject drugs or reside in rural and frontier areas had low vaccine uptake while PLWH who were engaged in care, enrolled in the AIDS Drug Assistance Program, and vaccinated against influenza had high vaccine uptake. Greater advocacy, education, and care navigation are required to increase COVID-19 vaccine access and uptake among PLWH. Supplementary Information The online version contains supplementary material available at 10.1007/s10461-021-03570-9.
- Published
- 2022